Back to search
FDAFDA · Food and drugs·Recall number D-0002-2021

RIOMET ER (metformin hydrochloride for extended-release oral suspension), 500 mg per 5 mL 16 oz. For Oral Use Only Rx Only Manufactured by: Sun Pharmaceuticals Industries Limited Mohali, India Distributed by: Sun Pharmaceuticals Industries, Inc. Cranbury, NJ 08512 NDC 10631-019-17

Published October 7, 2020 · Recall initiated: September 23, 2020

Summary

FDA records drug Class II recall D-0002-2021, published October 7, 2020 and initiated September 23, 2020. Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC; Status: Terminated; Reported quantity: 747 bottles; Lot: Lot #: AB06381; Exp 10/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Detection of N-nitrosodimethylamine (NDMA) impurity in finished drug product.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
SUN PHARMACEUTICAL INDUSTRIES INC
Distributor
Nationwide
Lot
Lot #: AB06381; Exp 10/2021
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was RIOMET ER (metformin hydrochloride for extended-release oral suspension), 500 mg per 5 mL 16 oz. For Oral Use Only Rx Only Manufactured by: Sun Pharmaceuticals Industries Limited Mohali, India Distributed by: Sun Pharmaceuticals Industries, Inc. Cranbury, NJ 08512 NDC 10631-019-17 recalled?

Yes. FDA published recall D-0002-2021 on October 7, 2020. Reported hazard: CGMP Deviations: Detection of N-nitrosodimethylamine (NDMA) impurity in finished drug product.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release